isomethyleugenol has been researched along with Central Nervous System Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, K; Li, K; Liu, M; Lv, J; Xing, L; Zhong, X | 1 |
| Chlamydas, S; Markouli, M; Piperi, C; Strepkos, D | 1 |
| Scott, JM; Weir, DG | 1 |
| Clarkson, TW; Norseth, T | 1 |
| Baumann, NA; Harpin, ML; Jacque, CM; Pollet, SA | 1 |
3 review(s) available for isomethyleugenol and Central Nervous System Disease
| Article | Year |
|---|---|
Role of N6-methyladenosine modification in central nervous system diseases and related therapeutic agents.
Topics: Central Nervous System Diseases; Humans; Methylation; Methyltransferases; RNA | 2023 |
Histone lysine methyltransferase SETDB1 as a novel target for central nervous system diseases.
Topics: Central Nervous System Diseases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lysine; Methylation | 2021 |
The biochemical basis of the neuropathy in cobalamin deficiency.
Topics: Animals; Central Nervous System Diseases; Humans; Methylation; Vitamin B 12 Deficiency | 1995 |
2 other study(ies) available for isomethyleugenol and Central Nervous System Disease
| Article | Year |
|---|---|
Studies on the biotransformation of 203Hg-labeled methyl mercury chloride in rats.
Topics: Animals; Biotransformation; Brain Chemistry; Central Nervous System Diseases; Chlorides; Feces; Female; Kidney; Mercury; Mercury Isotopes; Methylation; Organometallic Compounds; Rats; Time Factors | 1970 |
Fatty acid and lipid composition of the brain of a myelin deficient mutant, the "quaking" mouse.
Topics: Animals; Brain Chemistry; Central Nervous System Diseases; Cerebrosides; Chromatography, Gas; Chromatography, Thin Layer; Fatty Acids; Genes, Recessive; Lipid Metabolism; Male; Methylation; Mice; Mutation; Phospholipids; Sphingomyelins | 1968 |